{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:41:36Z","timestamp":1781134896091,"version":"3.54.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>Heparins, unfractionated heparin, and low molecular weight heparin, are the preferred anticoagulants in pregnancy. There are circumstances, however, in which an alternative to heparin should be considered. These circumstances include, the presence of heparin resistance, a heparin allergy manifesting as heparin-induced skin reactions or heparin-induced thrombocytopenia, and the presence of a mechanical heart valve. From time to time, the obstetrician is called on to make recommendations about anticoagulants in pregnancy, including in circumstances in which an alternative to heparin has been suggested or is necessary. In this article, these circumstances are reviewed and alternative anticoagulants are discussed.<\/jats:p>","DOI":"10.1097\/grf.0000000000000357","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T18:59:24Z","timestamp":1519239564000},"page":"228-234","source":"Crossref","is-referenced-by-count":12,"title":["Prevention and Management of Thromboembolism in Pregnancy When Heparins Are Not an Option"],"prefix":"10.1097","volume":"61","author":[{"given":"ANDRA H.","family":"JAMES","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jth.12085","article-title":"Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature","volume":"11","author":"Romualdi","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/AOG.0b013e3182310c4c","article-title":"Practice bulletin no. 123: thromboembolism in pregnancy","volume":"118","author":"James","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.115.015242","article-title":"Pregnancy in women with a mechanical heart valve: data of the european society of cardiology registry of pregnancy and cardiac disease (ROPAC)","volume":"132","author":"van Hagen","year":"2015","journal-title":"Circulation"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-015-1309-0","article-title":"Guidance for the treatment and prevention of obstetric-associated venous thromboembolism","volume":"41","author":"Bates","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00132580-200103000-00010","article-title":"Bivalirudin: a new approach to anticoagulation","volume":"3","author":"Nawarskas","year":"2001","journal-title":"Heart Dis"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0267659115583525","article-title":"Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery","volume":"31","author":"McNair","year":"2016","journal-title":"Perfusion"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCRESAHA.112.264903","article-title":"Translational success stories: development of direct thrombin inhibitors","volume":"111","author":"Coppens","year":"2012","journal-title":"Circ Res"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","article-title":"Drug transfer and metabolism by the human placenta","volume":"43","author":"Syme","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0034-1398382","article-title":"Efficacy of argatroban in critically ill patients with heparin resistance: a retrospective analysis","volume":"41","author":"Treichl","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00132580-200105000-00009","article-title":"Argatroban: a direct thrombin inhibitor for heparin-induced thrombocytopenia and other clinical applications","volume":"3","author":"Chen","year":"2001","journal-title":"Heart Dis"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1432-1033.1977.tb11730.x","article-title":"The size and shape of human and bovine antithrombin III","volume":"78","author":"Nordenman","year":"1977","journal-title":"Eur J Biochem"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2017.05.017","article-title":"Management of hereditary antithrombin deficiency in pregnancy","volume":"157","author":"James","year":"2017","journal-title":"Thromb Res"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1941874415591500","article-title":"Heparin resistance and anticoagulation failure in a challenging case of cerebral venous sinus thrombosis","volume":"6","author":"King","year":"2016","journal-title":"Neurohospitalist"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1538-7836.2010.03926.x","article-title":"Fondaparinux as an alternative anticoagulant therapy during pregnancy","volume":"8","author":"Knol","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/187152571302151217124957","article-title":"Management and outcome of heparin-induced thrombocytopenia in pregnancy: a systematic review","volume":"13","author":"Chaudhary","year":"2015","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0140-6736(12)60409-7","article-title":"Heparin-induced skin lesions","volume":"380","author":"Schindewolf","year":"2012","journal-title":"Lancet"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/14767050600886666","article-title":"Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves","volume":"19","author":"James","year":"2006","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201806000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:12:48Z","timestamp":1694419968000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201806000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000357","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}